Financial Data and Key Metrics Changes - GAAP revenue increased to $7.739 million in 2024 from $7.355 million in 2023, driven by higher demand for mobile systems and IHP corporate service revenue [51] - Non-GAAP revenue was approximately $8 million, reflecting nearly a 6% increase over 2023 [52] - GAAP net loss was $4.477 million or $0.22 per share compared to a net loss of $3.403 million or $0.17 per share in the prior year [57] Business Line Data and Key Metrics Changes - Mobile equipment sales totaled approximately $3.8 million in 2024, reflecting a 23% growth compared to 2023 [54] - Service revenue generated around $2 million, a 23% increase from the previous year [54] - BIT solution sales reached approximately $900,000, marking a 9% growth [54] Market Data and Key Metrics Changes - The IHP corporate service division secured contracts extending through 2026, with a 42% increase in Q1 2025 compared to the same period last year [29] - Distribution arrangements resulted in 13 partners, leading to approximately $930,000 in sales for 2024 [27] Company Strategy and Development Direction - The company aims to expand the SteriMIST IHP brand globally and has established valuable partnerships in key markets [16] - Focus on enhancing sales infrastructure by establishing new distribution channels and recruiting independent representatives [59] - Plans to nurture the pipeline of CES hybrid and SIS sales to positively impact revenue in 2025 and beyond [60] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future growth, highlighting early successes in 2025 and a healthy pipeline [15][16] - The company is focused on returning to sustainable positive cash flow as soon as possible [50] - Management acknowledged challenges in the global food market but emphasized ongoing collaborations to address these issues [30] Other Important Information - The company has reduced R&D expenses by 41%, advertising and sales commissions by 17%, and consulting expenses by 20% in 2024 [48] - The company is actively pursuing new EPA labels to support growth within the cannabis and food safety industries [69] Q&A Session Summary Question: Revenue guidance for the year and margin information - Management indicated that margins should remain around current levels and expects additional wins to follow throughout the year [85][89] Question: Impact of tariffs on the company - Management does not anticipate significant ramifications from the tariff situation at this time [100] Question: Adequacy of cash levels to address opportunities - Management is looking to raise funds and believes current cash levels, along with accounts receivable, will be sufficient [102] Question: Status of FDA ruling for 1% solution for food products - Management stated it is hard to predict due to changes within regulatory agencies [110] Question: Modifications to SteriPak - Management confirmed that they are considering upgrades to surface units but are currently marketing the existing SteriPak [112]

FREDERICK, Md., April 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2024 financial results. TOMI Chief Executive Officer, Dr. Halden Shane, stated, "For the year ended December 31, 2024, we increased our year-over-year annual revenue by 5%, continu ...

Financial Performance - For the year ended December 31, 2024, total net sales increased by 5% to $7,739,000 compared to $7,355,000 in 2023[8] - Non-GAAP gross sales for the year were $7,966,000, reflecting a 6% increase from $7,483,000 in the previous year[8] - GAAP net loss for the year was $(4,477,000) or $(0.22) per share, compared to $(3,403,000) or $(0.17) per share in 2023[8] - SteraMist product-based revenues increased to $6,035,000 for the year, up from $5,781,000 in 2023, driven by higher demand for mobile and SIS units[8] - Net sales for the year ended December 31, 2024 were $7,738,842, an increase of 5.2% compared to $7,354,564 in 2023[30] - Gross profit for the year ended December 31, 2024 was $3,557,078, down 17.1% from $4,289,536 in 2023[30] - The net loss for the year ended December 31, 2024 was $4,476,762, compared to a net loss of $3,402,592 in 2023, representing an increase in loss of 31.6%[30] - Non-GAAP gross profit for the year ended December 31, 2024 was $4,789,078, an increase of 8.4% from $4,417,926 in 2023[31] - Non-GAAP net loss for the year ended December 31, 2024 was $2,049,912, compared to $2,838,399 in 2023, indicating a decrease in loss of 28%[31] Revenue Growth - International revenue grew by 33% for the year, supported by new customers in Canada, South Africa, and India[8] - Preliminary Q1 2025 revenues are expected to be approximately $1,577,000, a 42% increase from $1,114,000 in Q1 2024[19] - Sales backlog increased to $1,232,000 as of March 31, 2025, representing a 40% increase from December 31, 2024[19] Operational Metrics - The gross margin for the year was 46%, down from 58% in the prior year, while non-GAAP gross margin was 60%, up from 59%[8] - Operating expenses increased to $7,661,838 for the year ended December 31, 2024, compared to $7,638,813 in 2023, reflecting a slight increase of 0.3%[31] Assets and Liabilities - Total assets decreased from $13,357,614 in December 31, 2023 to $9,693,738 in December 31, 2024, a decline of approximately 27.5%[24] - Total liabilities increased from $4,998,720 in December 31, 2023 to $5,594,799 in December 31, 2024, an increase of approximately 11.9%[28] - Cash and cash equivalents decreased significantly from $2,339,059 in December 31, 2023 to $664,879 in December 31, 2024, a decline of about 71.6%[24] - Total shareholders' equity decreased from $8,358,894 in December 31, 2023 to $4,098,939 in December 31, 2024, a decline of approximately 51%[28] Future Outlook - The company anticipates continued improvement in 2025, driven by a strong pipeline and high-margin solution sales[9] - The company expanded partnerships with six new partners across various regions, enhancing its global distribution capabilities[8]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-09908 TOMI ENVIRONMENTAL SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Florida 59-1947988 (State or other jurisdiction ...

Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform [4] - The BIT solution employs a low percentage of hydrogen peroxide as its active ingredient, enhanced by patented ionized Hydrogen Peroxide (iHP) technology [4] - TOMI's products cater to a wide range of sectors, including hospitals, biosafety labs, pharmaceutical facilities, schools, and commercial buildings [4] Upcoming Financial Reporting - TOMI will report its fourth-quarter results for the period ending December 31, 2024, on April 14, 2025, after market close [1] - A conference call to discuss the results will take place at 4:30 p.m. ET on the same day [1] Participation Details - Participants can join the conference call by dialing (888) 506-0062 or (973) 528-0011 for international callers, using access code 818389 [2] - A replay of the teleconference will be available until April 28, 2025, with specific dialing instructions provided [3]

Core Insights - TOMI Environmental Solutions, Inc. has announced an OEM partnership with Pharma Biotech System Components LLC, enhancing its SteraMist Integrated System (SIS) product line [1][3] - The collaboration aims to leverage PBSC's expertise in high-containment solutions to expand the adoption of SteraMist in critical industries [3][4] - TOMI's SIS will now include pass-through hatches and chambers integrated with ionized Hydrogen Peroxide (iHP) technology for optimized decontamination cycles [1][4] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform [4] - The company’s products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, and commercial buildings [4] - BIT technology employs a low percentage of hydrogen peroxide as its active ingredient, providing superior disinfection capabilities [4] Industry Context - PBSC is recognized as a leading manufacturer of cleanroom and material decontamination products, catering to the pharmaceutical and medical research sectors [2] - The partnership is expected to meet the increasing demand for integrated disinfection solutions in high-containment environments [3][4] - Current projects are underway, indicating strong market demand for TOMI's innovative SIS system [3]

Core Insights - TOMI Environmental Solutions, Inc. has secured a significant contract valued at approximately $450,000 to install a SteraMist iHP Custom Engineered System at a leading university in Rhode Island, highlighting its competitive advantage over hydrogen peroxide competitors [1][2] - The demand for enhanced decontamination solutions among academic institutions is increasing, as TOMI's SteraMist technology demonstrates superior performance compared to traditional systems [2][3] - TOMI's SteraMist iHP technology is expected to remain a preferred choice for disinfection in Boston's life science industry, with additional sales secured at a private university in Massachusetts [3] Company Overview - TOMI Environmental Solutions specializes in disinfection and decontamination solutions, utilizing its proprietary Binary Ionization Technology (BIT) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [4] - The company’s products are designed for a wide range of applications, including hospitals, biosafety labs, pharmaceutical facilities, and educational institutions [4]

Core Insights - TOMI Environmental Solutions, Inc. has successfully implemented its SteraMist technology at Algafeed, addressing contamination issues in microalgae production for aquaculture [1][2] - Algafeed faced significant Protozoan ciliate contamination, which was effectively reduced through the use of SteraMist, allowing for improved production volumes [2][4] - The partnership between TOMI and Algafeed highlights the versatility of SteraMist technology in various industries, particularly in aquaculture [4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [5] - The company’s products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, schools, and food processing facilities [5] Industry Context - Algae serves as a primary food source in aquaculture, and Algafeed's innovative technology allows for high-density microalgae cultivation, providing a competitive edge in the industry [3] - The successful application of SteraMist technology in the aquaculture sector demonstrates the growing importance of effective disinfection solutions in maintaining production efficiency [2][4]

Core Insights - TOMI Environmental Solutions, Inc. has successfully deployed its SteraMist iHP technology at NASA Johnson Space Center, marking its entry into the aerospace sector [1][2] - The technology is being utilized in a biosafety cabinet for handling samples from the Mars Perseverance Rover mission, demonstrating its application in space exploration [2][3] - This deployment is part of TOMI's strategic SteraMistX campaign, which aims to enhance biosecurity standards in aerospace and military fields [4] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in disinfection and decontamination solutions, utilizing technology developed through DARPA [1][5] - The company's primary product, the Binary Ionization Technology (BIT) platform, employs a low percentage of hydrogen peroxide as its active ingredient, providing superior disinfection capabilities [5] - TOMI's products are designed for a wide range of environments, including hospitals, biosafety labs, pharmaceutical facilities, and more [5]

Group 1 - TOMI Environmental Solutions, Inc. will participate in the Q1 Investor Summit Event on March 11, 2025, with Dr. Halden Shane as the representative [1][2] - The conference will include one-on-one meetings for investors, allowing for direct engagement with the company [2] - TOMI specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, primarily marketed under the SteraMist brand [3] Group 2 - The BIT platform utilizes a low percentage of hydrogen peroxide as its active ingredient, employing patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [3] - TOMI's products are applicable in various environments, including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings [3]